American Society of Clinical Oncology

SHERPA: White

People

  1. Dickson
    Dickson
  2. D'Angelo
    D'Angelo
  3. Gounder
    Gounder
  4. Keohan
    Keohan
  5. Tap
    Tap
  6. Qin
    Qin
  7. Scher
    Scher
  8. Ginsberg
    Ginsberg
  9. Schwartz
    Schwartz
  10. Chi
    Chi

Groups

  1. Nursing (99)
  2. Radiology, Department of (99)
  3. Department of Medicine (85)
  4. Solid Tumor Oncology Division (80)
  5. Body Imaging Service (72)
  6. Epidemiology and Biostatistics (54)
  7. Biostatistics Service (52)
  8. GSK Faculty (43)
  9. Hematologic Malignancies, Division of (38)
  10. Survivorship Research (36)
Search Within
  1. "Nursing"
  2. "Radiology, Department of"
Formats
  1. Meeting Abstract (72)
  2. Journal Article (27)
Groups
  1. Nursing (99)
  2. Radiology, Department of (99)
  3. Department of Medicine (85)
  4. Solid Tumor Oncology Division (80)
  5. Body Imaging Service (72)
  6. Epidemiology and Biostatistics (54)

More Groups

People
  1. Mark Dickson (17)
  2. Sandra D'Angelo (16)
  3. Mary Keohan (15)
  4. Mrinal Gounder (15)
  5. Sujata Patil (15)
  6. William Tap (15)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (7)
  4. 2020 (6)
  5. 2019 (8)
  6. 2018 (7)

More Years

Publications
  1. Journal of Clinical Oncology (97)
  2. JCO Precision Oncology (2)

Results (99)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma
    Meeting Abstract

    Batlevi, C. L.; De Frank, S.; Stewart, C.; Hamlin, P. A.; Matasar, M. J.; Gerecitano, J. F.; Moskowitz, A. J.; Hamilton, A. M.; Zelenetz, A. D.; Drullinsky, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multicenter phase IB trial of carboxyamidotriazole orotate and temozolomide for recurrent and newly diagnosed glioblastoma and other anaplastic gliomas
    Journal Article

    Omuro, A.; Beal, K.; McNeill, K.; Young, R. J.; Thomas, A.; Lin, X.; Terziev, R.; Kaley, T. J.; DeAngelis, L. M.; Daras, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase I study of convection enhanced delivery (CED) of (124)I-8H9 radio-labeled monoclonal antibody in children with diffuse intrinsic pontine glioma (DIPG)
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Taskar, N.; Zanzonico, P.; Zhou, Z.; Donzelli, M.; Lyashchenko, S. K.; Haque, S.; Thakur, S. B.; Cheung, N. K. V.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL)
    Meeting Abstract

    Batlevi, C. L.; Hamlin, P. A.; Matasar, M. J.; Horwitz, S. M.; Gerecitano, J. F.; Moskowitz, C. H.; Straus, D. J.; Zelenetz, A. D.; Drullinsky, P.; Copeland, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase IB study of selinexor, a first-in-class inhibitor of nuclear export, in patients with advanced refractory bone or soft tissue sarcoma
    Journal Article

    Gounder, M. M.; Zer, A.; Tap, W. D.; Salah, S.; Dickson, M. A.; Gupta, A. A.; Keohan, M. L.; Loong, H. H.; D'Angelo, S. P.; Baker, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase Ib/II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Chi, P.; Qin, L. X.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Shoushtari, A. N.; Condy, M. M.; Konen, T.; Fruauff, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • First stage results of a phase II trial of sorafenib plus doxorubicin (SD) in patients (pts) with advanced hepatocellular carcinoma (HCC) who progressed (POD) on sorafenib (S)
    Meeting Abstract

    Abou-Alfa, G. K.; Capanu, M.; Do, R. K. G.; Hollywood, E.; Ly, M.; Chou, J. F.; Lee, J. K.; Connell, L. C.; Wan, P. J.; Bradley, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II trial of veliparib (V) in patients (pts) with previously treated BRCA or PALB2-mutated (mut) pancreas adenocarcinoma (PC)
    Meeting Abstract

    Lowery, M. A.; Kelsen, D. P.; Smith, S. C.; Moore, M.; Kindler, H. L.; Golan, T.; Segal, A.; Hollywood, E.; Maynard, H.; Capanu, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Journal Article

    Dang, C.; Iyengar, N.; Datko, F.; D'Andrea, G.; Theodoulou, M.; Dickler, M.; Goldfarb, S.; Lake, D.; Fasano, J.; Fornier, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save